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Achvltles of the rate-hmltmg enzymes of the cytldme pathway for the synthesis of phosphatldylchohne and 
phosphatldylethanolamme are neghglble m differentiated mouse gastrocnemms. whereas that of the respec- 
tlve proposed de novo glycerophosphodlester pathways IS high m this muscle Rates of de novo glycerophos- 
phorylchohne synthesis m dystrophlc mouse gastrocnemms are about half that of the wild-type homo- 
zygotes, whereas that of the heterozygotes IS near the mean of the two homozygous groups These results 
suggest that defective de novo synthesis of glycerophosphorylchohne IS the primary lesion m murme dy mus- 
cular dystrophy 
Muscular dystrophy Phosphattdylchohne Phosphollptd Glycerophosphorylchohne Fatty acid 
1 INTRODUCTION 
Among the various hypotheses proposed to ex- 
plain the etiology and pathology of muscular 
dystrophies, the myogemc membrane lesion hy- 
pothesis has received the most experimental 
support [l-3]. In spite of the large body of 
research generated by this hypotheses, the primary 
lesion of Duchenne (DMD), murme (MMD) and 
other hereditary muscular dystrophies remains 
unknown 
New pathways for the synthesis of acyl-spectftc 
phosphatrdylcholine (PC) and phosphatrdyletha- 
nolamine (PE) species have recently been postulated 
[4]. In these metabolic sequences, the glycerophos- 
phodtesters glycerophosphorylcholme (GPC) and 
glycerophosphorylethanolamme (GPE) are re- 
quired intermediates in the syntheses of these PC 
Abbrevtatums. DMD, Duchenne muscular dystrophy, 
MMD, murme dy muscular dystrophy, C22 6(n - 3), 
all-crs-4,7,10,13,16,19-docosahexaenoate, GP, sn-3-gly- 
cerophosphate, GPC, glycerophosphorylchohne; PC, 
phosphatldylcholme, PE, phosphatldylethanolamme, 
SR, sarcoplasmlc reticulum 
and PE species, respectively. Of these new se- 
quences, the cytrdine pathway-independent syn- 
theses of glycerophosphodtesters have been postu- 
lated to operate m voluntary muscle, which may 
lack the cyttdme pathways for the synthesis of PC 
and PE [4]. 
GPC levels are decreased to less than 10% m the 
gastrocnemius of DMD pattents [5,6]. A search for 
a mechanism for the decrease m this glycerophos- 
phodtester, based on the previously accepted path- 
ways of PC metabolism, has been unsuccessful 
[6,7]. Concomttant with the decrease in muscle 
GPC concentratton 1s a significant decrease m PC 
which has been conststently observed at early 
stages of the disease m DM [S-lo] and murme dy 
muscular dystrophy (MMD) [ 1 l-131, which can- 
not be accounted for by adipose or connective 
tissue infiltration. 
Interpretatton of the above data m light of the 
new proposed pathways of PC and PE synthesis 
[4] has led to the hypotheses that the de novo 
glycerophosphodtester pathways, and not the 
cyttdine pathways, carry most of the flux of PC 
and PE synthesis m differentiated voluntary mus- 
cle, and that a defect in GPC syntheses (such as m 
PC : sn-3-glycerolphosphate cholmetransferase) 
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may be implicated m the molecular etiology of 
DMD and MMD (a more complete account of this 
hypothesis can be found in [14]). This paper pro- 
vides evidence m support of some of the proposals 
of both hypotheses [4,14] m the mouse. 
2 MATERIALS AND METHODS 
2.1. Ammals 
Phenotypically normal (+ /?) and dystrophic 
(dy/dy) 12-week-old male mice of the C57BL/6J 
strain were a gift from Dr John Leonard, who ob- 
tamed them from the Jackson Laboratory (Bar 
Harbor, ME). Heterozygous (dy/ + ) and wild type 
homozygous ( + / + ) 9-week-old breeding pairs of 
the C3H/HeN strain were a gift of Dr W.T. Wat- 
son from the National Institutes of Health 
(Bethesda, MD). The dy/dy mdividuals can 
reproduce m this strain for 2-3 months, thus 
obligate heterozygotes were obtained from dy/dy 
x + / + matings. Dystrophtc mice m this strain 
were obtained from dy/+ x dy/+ or dy/dy x 
dy/ + matings. 9-week-old mdtvrduals were used. 
All animals were fed pelleted Purina mouse chow 
ad libitum. The Center for Research Animal 
Resources’ guide for the care and use of laboratory 
animals of Cornell University was followed. 
2.2. Chemrcals 
UTP, GPC, GPE, GP, glycerol, and bovine 
brain PC and PE were obtained from Sigma (St. 
Louis, MO), MgClz (1 .O M solution) was obtained 
from Fisher Scientific (Fan Lawn, NJ). L- 
[U-‘4C]Glycerol 3-phosphate (144 mCi/mmol) and 
[U-14C]glycerol (140 mCt/mmol) were purchased 
from New England Nuclear (Boston, MA) with 
confirmed radiopurrties of > 99.5%. [cholme- 
Me-14C]Phosphatidylcholine (117 mCi/mmol) was 
obtained from ICN (Irvine, CA). All common 
chemicals were of reagent grade or of the highest 
purity available. 
2.3. Enzyme preparation 
Animals were killed by cervical dislocation. 
Gastrocnemn were immediately excised, blotted, 
and homogenized m 5 vols of ice-cold 0.25 M 
sucrose. Post-nuclear and connective tissue-free 
supernatants were obtained by centrifugation at 
600 x g for 10 mm, at 4°C. 
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2.4. Enzyme assays 
Choline kmase (EC 2 7.1.32), phosphorylcho- 
line cytidylyltransferase (EC 2.7.7.15), ethanol- 
amine kmase (EC 2.7.1.31) and phosphoryletha- 
nolamine cytidylyltransferase (EC 2.7.7.14) were 
assayed as indicated m [15,16]. Unless otherwise 
indicated, GPC synthetase (PC : GP cholinetrans- 
ferase) and GPE synthetase (PE:GP ethanol- 
ammetransferase) were assayed in a medmm con- 
taining: 5.0 mM MgUTP2-, 0.54 mM [14C]GP 
(2.6 mCi/mmol), 2.3 mM free Mg’+, 80 mM 
Hepes pH 7.0 (pH optimum 7.0-7.5), and between 
0.25 and 1.8 mg of tissue supernatant protein, m a 
total volume of 0.375 ml. In mcubattons with 
[i4C]PC (117 mCr/mmol), labelhng of the endog- 
enous PC pool was attempted by addition of 
1.0 nmol radtoactrve PC followed by somcation; 
other added reactants were as in the assay with 
labelled GP Initial velocities were obtained with 
30 mm mcubations at 37°C Reaction rates were 
first order with respect o protem concentration at 
the above protein levels. All assays were stopped 
with 0.050 ml of 1.0 M perchlorrc acid and cen- 
trifuged at 600 x g for 5.0 mm to preciprtate 
phosphohpids and denatured protems. Ahquots 
(0.020 ml) of the protein- and phosphohptd-free 
supernatants were subsequently analyzed for 
substrates and products. 
2.5. Analytrcal 
Choline, phosphorylcholme, CDP-chohne, 
ethanolamine, and their corresponding dertvattves, 
were resolved and identified as described in 
[ 15-171, GP, GPC, GPE and glycerol were tden- 
tified by Whatman DE-81 anion exchange paper 
chromatography, with a solvent system consisting 
of 30 mM NaCl m 75% ethanol; Rf values are GP, 
0 05; GPE, 0.31; GPC, 0.58; glycerol, 0.82. This 
chromatographic system was also used to resolve 
the reaction products m assays with labelled PC, m 
whrch Rr values for phosphorylcholme, GPC and 
cholme are 0.30, 0.58, and 0.85, respectively. GP, 
GPE and GPC were identified using phosphomo- 
lybdtc phosphorus reagent 1181. Glycerol was tden- 
tified by the benzidme-metaperiodate r agent [191. 
Radioactivity was measured by hquid scmtrllation 
spectrometry. Recovery of radroactivity was 
always higher than 98% 
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2.6. Miscellaneous 
Concentrations of the various hgands and Mg 
species were calculated from solutions of the cor- 
responding multiple equilibria equations [20], and 
the appropriate binding constants [21,22]. Protein 
was determined by the Folin phenol reagent [23] 
with crystalline bovine serum albumin as a stan- 
dard. Statistical analysis was performed by a com- 
puterized t-test (MINITAB, Statistics Dept, Penn- 
sylvania State University). 
3. RESULTS 
Activities of the phosphoryltransferases and 
cytidylyltransferases, which are the only rate- 
limitmg steps of the cytidine pathway for PC and 
PE synthesis [ 15,16,24,25], showed neghgrble ac- 
tivities in the gastrocnemius of C57BL/6J mice. 
Activities of choline kinase, P-cholme cytidylyl- 
transferase and that of the ethanolamine analogs 
showed rates of less than 0.004 nmol/mg protein 
per min (not shown). No significant differences (P 
= 0.10) between the + /? and dy/dy genotypes 
were observed. These activities were less than 1% 
of that of liver (unpublished). Activities of the 
non-rate-hmrting CDP-choline : sn-1,2-DG P- 
cholmetransferase showed rates less than 0.01 
nmol/mg protein per mm in both dystrophrc and 
normal phenotypes in both mice strains. No sig- 
nificant differences (P = 0.10) were observed 
among the various phenotypes. These actrvrtres 
were about 5% of that of liver tissue (unpub- 
lished). 
Chromatographrc analyses of GPC and GPE 
synthetase assays showed that more than 93% of 
the radioactive reaction products comigrated with 
GPE and GPC authentic standards when [14C]GP 
was the labelled substrate. The rest of the counts 
comigrated with free glycerol, indicating that the 
enzyme preparation contained some residual phos- 
phatase activity on GP. MgUTP’- was included m 
the assay protocol as a GP phosphorylhydrolase 
competitive substrate; rates of GP hydrolysis were 
reduced by 70% by this nucleotide. However, 
other effects of this nucleotide cannot be ruled out 
at this time. In assays with [14C]PC as cholme 
donor for GP, greater than 95% of the radioactive 
reaction products comigrated with authentic GPC. 
The rest of the radioactivity comtgrated wrth phos- 
phorylcholine and choline, which are probably 
phospholipase C (EC 3.1.4.3) and D (EC 3.1.4.4) 
products. Some of the requuements of the GPC 
and GPE synthetases are shown in table 1, which 
indicates that the requirements for GP and Mg2+ 
are absolute. Addition of non-labelled PC or PE 
drd not increase the reaction rates significantly, 
suggesting that under the assay conditions these 
base donors are not rate-hmrting. Since the con- 
centrations of endogenous choline and ethanol- 
amme donors did not seem hmitmg, subsequent 
assays were performed with [14C]GP wtthout ex- 
ogenous phospholipids. Further evidence consts- 
tent with the proposal that de novo synthesized 
GPC from GP is an intermediate in the synthesis 
of PC m mouse muscle is the fact that unlabelled 
GPC acts as an effective isotope trap to decrease 
labelled GP incorporation into PC, while its mcor- 
poration into PE is not inhibited, in an in vitro 
system containing C22 : 6(n-3) (unpublished). 
Initial experiments with lZweek-old C57BL/6J 
mice indicated that the dystrophic individuals had 
a GPC synthetase activity 10% of that of the litter- 
mates, while the rates of GPE synthesis were about 
l/3 that of the controls (table 2). This difference 
Table 1 
Requirements of glycerophosphorylchohne (GPC) and 
glycerophosphorylethanolamme (GPE) synthesis of 
9-week-old C3H/HeN + / + mouse gastrocnemms 
Reactants GPC GPE 
synthesisa synthesisa 
Complete [14C]GP assay 5453 f 327 143 f 37 
+ 0.5 mM PC 5512 f 302 759 f 33 
+05mMPE 5423 Z!Z 285 186 k 35 
- MgUTP’- 3452 f 318 345 rt 21 
- Mg’+ 91 + 12 154 + 28 
- [14C]GP + [‘4C]glycerol 76 f 13 191 f 21 
- enzyme 40 + 9 136 f 24 
Complete [14C]PC assay 1503 f 85 -b 
-GP 114 + 15 - 
- Mg2+ 85 + 17 - 
- enzyme 71 + 19 _ 
a Supernatant protem was 1 5 mg Substrates and 
products were resolved by DE-81 amon exchange 
paper chromatography with solvent system D. Other 
assay procedures were as Indicated m section 2 
b Not determmed 
Results are expressed m cpm f SD (n = 2) 
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Table 2 
Rates of giycerophosphoryichoiine (GPC) and glycerophosphoryiethanoIam~ne 
(GPE) synthesis (nmol product/mg protem per mm 2 SD) m gastrocnemlus of 
C57BL/6J and C3WHeN mice 
Stram Genotype GPC synthesis GPE synthesis 
C57BL/6J +/? (n = 4) 0 70 + 0.36 0.36 + 0 10 
dy/dy (n = 4) 0 07 F 0 08” 0 13 * 0 07b 
C3HIHeN +/+ (n = 6) 1 04 rt 0 21 0 12 rt 003 
dy/ + (n = 5) 0 74 -+ 0 12’ 0 13 k 002 
dy/dy (n = 5) 0 48 i7 0 21d 0 21 r?: 0 05’ 
ady/dy< +/?atP=O0073 
bdy/dy< +/?atP=O0055 
‘dy/+ < +I+ atP=O0172 
‘dy/dy<dyl+ atP=O0376anddy/dy< +/+ atP=O0017 
edy/dy>dy/+ atP=O0080anddy/dy> -t/-t atP=OOO98 
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suggested that the primary cause of the disease 
might be a defective GPC synthetase. However, at 
this age the clmtcal picture of the disease 1s 
somewhat advanced m the C57BL/6J genetic 
background. Therefore, the posslblhty that the 
lower rates of GPC and GPE synthesis are sec- 
ondary to the primary molecular lesion could not 
be ruled out. Assay of obligate heterozygotes m 
this strain was not possible since the dy/dy 
genotype does not breed and the dy/ + genotype 1s 
clmlcally mdlstmguishable from the +/+ wild 
type. 
As the dy gene m the C3H/He background 
shows a reduced expressjon and penetrance 1261, 
the dy/dy mdlvlduals were able to breed GPC syn- 
thetase assays m tissues with less advanced 
pathology, as well as the avallablhty of obligate 
tamers, greatiy increased the dlscrlmmatmg power 
of these experiments with this strain. 
GPC synthetase activity of the gastrocnemms m 
the dy/dy mdlvlduals of the C3H/HeN strain was 
about 50% that of the wild type homozygotes, 
while the activity m the heterozygotes was near the 
mean of the two homozygous groups (table 2). The 
rate of GPE synthesis m the dyldy individuals, on 
the other hand, was nearly twice that of the wild 
type homozygotes (table 2) The C3H/HeN 
heterozygote GPE synthetase activity, however, 
was mdlstmguishable from that of the + /+ m- 
dlvlduals. The rate of GPC synthesis m the dy/dy 
indlvlduals was higher m the C3H/HeN 
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background than m the C57BL/6J background 
(table 2). 
4. DISCUSSION 
The negligible actlvltles of the two rate-hmltmg 
reactions of the cytldme pathway for PC and PE 
synthesis are consistent with the previous sugges- 
tion that these sequences do not operate m muscle 
[4,14]. Low actlvltles of the terminal phosphor- 
ylated base transferases of the cytldme pathway 
have also been observed m dlfferentlated muscle of 
mice and of other species 127-291. 
It 1s difficult to establish the primary molecular 
defect m genetic diseases by biochemical assays of 
the affected tissues, since any observed differences 
with normal tissue may be due to associated sec- 
ondary effects, which are elicited as a consequence 
of the primary lesion. Slgmficant differences be- 
tween the 12-week-old dystrophlc and normal 
(+ /7 phenotypes were obtained m the C57BL/6J 
and C3H/HeN strains m the rates of GPC and 
GPE synthesis However, the rates of GPC and 
GPE synthesis m dystrophic mice of the Jackson 
strain were much lower than m those of the NIH 
stram (table 2). The fact that the heterozygotes of 
this strain do not show an actlvatlon of GPE syn- 
thesis suggests that this genotype can conserve 
GPC solely by decreased catabolism, 1.e lower 
GPC phosphodlesterase. GPE and GPC syn- 
thetases, if membrane bound, may require the end 
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product of GPC synthetase for activity, i.e. highly 
unsaturated PC species. Therefore, a negative 
feed-back loop may be established as a conse- 
quence of the primary defect m GPC synthesis. 
This would further decrease the rate of GPC syn- 
thesis, accelerating the progress of the disease. 
Likewise, this negative feed-back loop would make 
the compensatory expansion of the GPE-orig- 
inated C22 : 6(n - 3)PE-dependent GPC reacyla- 
tion pathway [4] only transitory. Therefore, the 
lower rates of GPE synthesis observed m the 
C57BL/6J-dy/dy mdividuals (table 2) would sug- 
gest that the disease m this Jackson strain is 
already too advanced in the 12-week-old animals. 
On the other hand, the increased rate of GPE syn- 
thesis observed in the 9-week-old dy/dy mice of the 
C3H/HeN strain suggests that at this age the sec- 
ondary effects of the primary lesion are not yet 
apparent. 
A better strategy to locate the primary lesion of 
a genetic disease with recessive xpression is to test 
the hypothesis in the target tissue of non-affected 
heterozygotes. In this genotype the ambiguity m- 
traduced by secondary pathology can be ruled out, 
or at least reduced to a minimum. This approach 
in the C3H/HeN strain showed that the dy/+ 
mice had a GPC synthetase activity near the mean 
of the two homozygous groups (table 2), since the 
heterozygotes have half the gene dosage of each 
homozygote This pattern of enzyme activity, in 
the heterozygote, is expected for monomeric pro- 
teins which do not show allelic mteracttons which 
could otherwise produce heterosis. The fact that 
the heterozygotes have an enzyme activrty around 
the mean of both homozygous groups also 
validates that GPC synthetase measurements of 
the 9-week-old dy/dy genotype of the C3H/HeN 
were done early enough that secondary pathology 
of the disease did not seriously interfere with it, as 
was the case for the C57BL/6J strain. 
The vartable penetrance and expressivity of the 
dy gene in different genetic backgrounds [26] may 
originate from epistatic interactions between 
genettc polymorphism of the proposed conserva- 
tion, catabolic and de novo pathways for 
SR C22:6(n-3)PC [14]. 
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